Benny Evison

Benny Evison Ph.D

Chief Scientific Officer

B. Sc. (Med. Sci.) (Hons); PhD

Benny brings to Nyrada, Inc an expertise in advancing drug compounds from the discovery phase into clinical trials in humans. His early interest in science led him to study at La Trobe University where he obtained a Bachelor of Medical Science with Honours, followed by a PhD. His PhD involved the identification of a potential new mechanism of action of a drug called pixantrone, which is currently used for the treatment of non-Hodgkin’s lymphoma. Following his PhD, he was keen to gain more training at an international level, so he moved to Memphis, Tennessee in the USA, where he was a postdoctoral fellow at St Jude Children’s Research Hospital. His time there with very sick children was a strong motivational factor to generate important scientific research. At St Jude Children's Research Hospital, he worked on making drugs that targeted proteins involved in DNA repair to improve the activity of existing chemotherapies, before returning to Australia to become one of the first scientists at Nyrada,Inc.